National Institutes of Health
FOR IMMEDIATE RELEASE
May 13, 2002
NCI Press Office
NCI Expands Treatment Trial Access to Patients and Oncologists Nationwide
The National Cancer Institute (NCI) today announced it is expanding access
to its clinical trials to more oncologists around the country.
policy allows cancer patients anywhere in the United States to participate
more easily in advanced (Phase III) treatment trials.
Under the new system, oncologists can become credentialed as investigators
and then can enroll patients in trials through NCI's Cancer Trials Support
Until now, the CTSU has been open only to members of NCI's
Cooperative Groups. The CTSU makes it easier for oncologists and patients
to take part in important trials that define the standard of care for lung,
breast, prostate, colorectal, and other cancers.
"This expansion allows every practicing oncologist in the country the
opportunity to take part in some of the most advanced cancer treatment
research," said Jeffrey S. Abrams, M.D., NCI project officer. "Soon,
patients who seek the new treatments available in clinical trials, whether
they live in the largest metropolis or the smallest rural community, will
not be forced to travel long distances to receive critical care."
Through the Web-based CTSU, oncologists are able to download protocols, case
report forms, and other documents associated with trials.
oncologists are reimbursed for research costs and their staffs can benefit
from on-line educational opportunities developed by the CTSU for which
continuing education credit (CEU) is available.
"Since July of 2000, the U.S. Cooperative Groups have been working with the
CTSU to develop and test systems ultimately designed to streamline the
clinical trials process for group physicians and their patients," said
Robert L. Comis, M.D., president of the Coalition of National Cancer
Cooperative Groups, which has worked with NCI to develop the CTSU.
"Expanding the opportunity for participation of interested physicians
outside the Group structure through the CTSU is a bold, new strategy to
broaden access, which will hopefully lead to more rapid trial completion
while maintaining the high quality of care associated with clinical trial
Interested physicians will undergo a two-phase application and credentialing
process, including a site visit, to ensure their capability to meet all
regulatory requirements and to collect research data successfully.
The CTSU will launch its new program May 18, 2002, to coincide with the
American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Fla.
For more information on the CTSU or to learn more about participating in the
program, please visit www.ctsu.org or call 1-888-823-5923.
# # #
For more information about cancer in general, please visit NCI's Web site at
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.